| 2025 | 2024 | 2023 | ||||
|---|---|---|---|---|---|---|
| Gross margin | 26,6 k € | +241.3% | 7,8 k € | -60.7% | 19,8 k € | |
| EBITDA | 25,9 k € | +264.2% | 7,1 k € | -61.4% | 18,4 k € | |
| Operating profit | 22,0 k € | +538.9% | 3,4 k € | -77.6% | 15,4 k € | |
| Profit/loss | 16,9 k € | +664.3% | 2,2 k € | -81.4% | 11,8 k € | |
| Equity | 34,9 k € | +93.4% | 18,1 k € | +13.9% | 15,8 k € | |
| Total assets | 41,6 k € | +49.4% | 27,9 k € | +23.5% | 22,6 k € | |
| Cash | 21,6 k € | +240.6% | 6,3 k € | -54.0% | 13,8 k € | |
| Debts | 6,7 k € | -31.6% | 9,8 k € | +46.1% | 6,7 k € | |
Source: Belgian Official Gazette
Private limited company · Woluwe-Saint-Pierre · incorporated on 03/06/2022
Private limited company profitable and well capitalised. Cash position rising (+240.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
DR.QUEEN is a Private limited company incorporated in 2022. Its registered office is in Woluwe-Saint-Pierre.